SG Americas Securities’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$97K Sell
10,435
-21,055
-67% -$196K ﹤0.01% 2343
2025
Q1
$231K Sell
31,490
-40,208
-56% -$295K ﹤0.01% 2172
2024
Q4
$612K Buy
71,698
+26,511
+59% +$226K ﹤0.01% 1002
2024
Q3
$393K Buy
+45,187
New +$393K ﹤0.01% 1691
2024
Q2
Sell
-28,946
Closed -$263K 2718
2024
Q1
$263K Buy
28,946
+9,300
+47% +$84.5K ﹤0.01% 1577
2023
Q4
$88K Buy
19,646
+7,404
+60% +$33.2K ﹤0.01% 2561
2023
Q3
$38K Buy
+12,242
New +$38K ﹤0.01% 2674
2023
Q2
Sell
-33,849
Closed -$178K 2553
2023
Q1
$178K Buy
+33,849
New +$178K ﹤0.01% 2294
2022
Q4
Sell
-15,285
Closed -$63K 2897
2022
Q3
$63K Buy
15,285
+5,191
+51% +$21.4K ﹤0.01% 2643
2022
Q2
$41K Buy
+10,094
New +$41K ﹤0.01% 2978
2022
Q1
Sell
-18,415
Closed -$128K 2860
2021
Q4
$128K Sell
18,415
-20,686
-53% -$144K ﹤0.01% 2638
2021
Q3
$391K Buy
+39,101
New +$391K ﹤0.01% 2497
2021
Q2
Sell
-15,072
Closed -$247K 2742
2021
Q1
$247K Buy
15,072
+4,294
+40% +$70.4K ﹤0.01% 2300
2020
Q4
$223K Buy
+10,778
New +$223K ﹤0.01% 2264
2020
Q3
Sell
-28,347
Closed -$236K 2670
2020
Q2
$236K Buy
28,347
+12,779
+82% +$106K ﹤0.01% 2340
2020
Q1
$77K Buy
+15,568
New +$77K ﹤0.01% 2614
2019
Q4
Sell
-10,553
Closed -$32K 2776
2019
Q3
$32K Buy
+10,553
New +$32K ﹤0.01% 2408
2017
Q2
Sell
-49,024
Closed -$455K 2866
2017
Q1
$455K Buy
+49,024
New +$455K ﹤0.01% 1711
2015
Q2
Sell
-2,471
Closed -$104K 2242
2015
Q1
$104K Buy
+2,471
New +$104K ﹤0.01% 1959